bharat biotech
PM Modi reviews Covid vaccine progress at Bharat Biotech
He congratulated the scientists for their progress in the trials so far
Bharat Biotech to launch Covaxin in second quarter of 2021
The price of the vaccine is yet to be determined, as the company is still looking at the cost of product development
Third phase human trial of COVAXIN to commence in Bhubaneswar
Dr Rao, head of PTCTU, said during this phase the age limit and eligibility/ screening criteria would be relaxed
Covaxin to use ViroVax's adjuvant Alhydroxiquim-II to boost immune response
Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India
Covaxin test on animals show sign of hope
The animal trials were conducted on 20 monkeys in India and three different vaccine candidates were tried on them
Bharat Biotech’s Covaxin shows ‘encouraging results’ in phase-I of human trials
Covaxin is one of the only two indigenous COVID vaccine candidates approved for human clinical trials in India
Seven Indian pharma players race to develop vaccine for deadly coronavirus
Leading vaccine major Serum Institute of India has said that it is hoping to develop a COVID-19 vaccine by the year-end
Zydus Cadila's potential covid drug may begin human clinical trials
India’s 'first' indigenous COVID-19 vaccine candidate Covaxin had also got the nod for human clinical trials recently
Bharat Biotech’s COVID-19 vaccine gets nod for human trials
Human trials are scheduled to start across the country in July, developed and manufactured in Bharat Biotech’s facility in Hyderabad